Dose selection for glycopyrrolate/eFlow® phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-finding studies
Author(s) -
James F. Donohue,
Thomas Goodin,
Robert Tosiello,
Alistair Wheeler
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qhkt-0s64
Subject(s) - glycopyrrolate , nebulizer , medicine , obstructive lung disease , phase (matter) , lung , anesthesia , atropine , pulmonary disease , chemistry , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom